Moreover, miR-145 was identified to suppress the expression of target genes WNT2B and WNT10A, which induced the inactivation of Wnt/β-catenin signalling and inhibited cell viability in CRC cells. The gene discussed is WNT10A; the disease is colorectal carcinoma.